VALVULAR DISEASES IN PREGNANCY

H. A. Parlakgumus, T. Bağış, B. Haydardedeoglu
{"title":"VALVULAR DISEASES IN PREGNANCY","authors":"H. A. Parlakgumus, T. Bağış, B. Haydardedeoglu","doi":"10.5505/TJOD.2011.48278","DOIUrl":null,"url":null,"abstract":"SUMMARY Important cardiovascular changes occur during pregnancy, labor and the postpartum period. Blood volume and erythrocyte mass increase, physiological anemia occurs and blood pressure decreases. Cardiac flow rate and stroke volume increase. Although healthy pregnant women can tolerate these changes, pregnant women with cardiac disease may get worse and the changes may cause risk for both the women and their fetuses. A valve disease with a favorable outlook before pregnancy may get worse when pregnancy is superimposed and pregnancy may have to be terminated. In such cases pregnancy plays an important part in selection of the type of treatment. Diagnostic methods and treatment alternatives should be appropriate for individual patients. Health professionals should give priority to maternal health rather than fetal health, mothers should be informed about possible risks and treatment alternatives should be discussed with them. Any treatment given to mothers may affect their fetuses and treatment should be selected accordingly. Mothers with a valve disease should undergo a thorough examination, should be informed about the risks of pregnancy and should be referred to tertiary health care centers before pregnancy and thereby they can give birth without problems. Management of valve diseases in pregnancy involves replacement of contraindicated drugs with safe ones, controlling conditions likely to cause cardiac loading, close follow-up and aggressive treatment of conditions aggravating the disease. Echocardiography should be performed to determine pulmonary pressure and all cardiac hemodynamics including the valves and when there are changes in symptoms, the patients should be evaluated in each trimester. Even if pregnancy is tolerated well, infections, anemia, arrhythmia, pulmonary embolus, pain and anxiety may worsen the condition. In these cases aggressive treatment is required. Physicians should know the maternal cardiovascular physiology well, should be equipped with latest relevant knowledge and should adopt a multidisciplinary approach during follow-up and labor.","PeriodicalId":174635,"journal":{"name":"Journal of Turkish Society of Obstetric and Gynecology","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Turkish Society of Obstetric and Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/TJOD.2011.48278","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

SUMMARY Important cardiovascular changes occur during pregnancy, labor and the postpartum period. Blood volume and erythrocyte mass increase, physiological anemia occurs and blood pressure decreases. Cardiac flow rate and stroke volume increase. Although healthy pregnant women can tolerate these changes, pregnant women with cardiac disease may get worse and the changes may cause risk for both the women and their fetuses. A valve disease with a favorable outlook before pregnancy may get worse when pregnancy is superimposed and pregnancy may have to be terminated. In such cases pregnancy plays an important part in selection of the type of treatment. Diagnostic methods and treatment alternatives should be appropriate for individual patients. Health professionals should give priority to maternal health rather than fetal health, mothers should be informed about possible risks and treatment alternatives should be discussed with them. Any treatment given to mothers may affect their fetuses and treatment should be selected accordingly. Mothers with a valve disease should undergo a thorough examination, should be informed about the risks of pregnancy and should be referred to tertiary health care centers before pregnancy and thereby they can give birth without problems. Management of valve diseases in pregnancy involves replacement of contraindicated drugs with safe ones, controlling conditions likely to cause cardiac loading, close follow-up and aggressive treatment of conditions aggravating the disease. Echocardiography should be performed to determine pulmonary pressure and all cardiac hemodynamics including the valves and when there are changes in symptoms, the patients should be evaluated in each trimester. Even if pregnancy is tolerated well, infections, anemia, arrhythmia, pulmonary embolus, pain and anxiety may worsen the condition. In these cases aggressive treatment is required. Physicians should know the maternal cardiovascular physiology well, should be equipped with latest relevant knowledge and should adopt a multidisciplinary approach during follow-up and labor.
妊娠期瓣膜疾病
重要的心血管变化发生在妊娠、分娩和产后。血量和红细胞增多,出现生理性贫血,血压下降。心流量和每搏量增加。虽然健康的孕妇可以忍受这些变化,但患有心脏病的孕妇可能会变得更糟,这些变化可能会给孕妇和胎儿带来风险。妊娠前前景良好的瓣膜疾病可能在妊娠叠加时恶化,妊娠可能不得不终止。在这种情况下,妊娠在选择治疗类型方面起着重要作用。诊断方法和治疗方案应适合个别患者。保健专业人员应优先考虑产妇健康而不是胎儿健康,应告知母亲可能存在的风险,并应与她们讨论替代治疗方案。对母亲的任何治疗都可能影响到胎儿,因此应选择相应的治疗方法。患有瓣膜疾病的母亲应接受彻底检查,应了解怀孕的风险,并应在怀孕前转诊到三级保健中心,这样她们就可以毫无问题地分娩。妊娠期瓣膜疾病的管理包括用安全药物替代禁忌药物,控制可能引起心脏负荷的情况,密切随访和积极治疗加重疾病的情况。超声心动图应确定肺动脉压和包括瓣膜在内的所有心脏血流动力学,当症状发生变化时,应在每个妊娠期对患者进行评估。即使妊娠耐受良好,感染、贫血、心律失常、肺栓塞、疼痛和焦虑也可能使病情恶化。在这些情况下,需要积极的治疗。医师应充分了解产妇的心血管生理,掌握最新的相关知识,在随访和分娩过程中应多学科结合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信